The medical device industry covers a wide range of categories. Full-category expansion tends to spread resources for R&D and quality control. Only by deeply cultivating a single niche segment can enterprises continuously develop stable and reliable products. Founded in 2010, Hainice has focused on medical devices for diabetes care since its inception, building a trustworthy domestic benchmark in this segment through specialized expertise.

Hainice concentrates all resources for R&D, production and services on complete blood glucose monitoring systems. It keeps refining product details for two core scenarios: home monitoring for diabetics and screening in primary clinics. Long-term accumulation of intellectual property exclusive to this niche prevents superficial R&D caused by scattered investment across multiple product lines.

Its production and inspection system is tailor-made for blood glucose monitoring devices, supported by dedicated test strip production lines and special stability testing equipment. Specific testing standards are formulated for the whole process of blood sampling, chemical reaction and reading. By concentrating on quality control optimization for segmented products, compared with manufacturers spanning multiple categories, Hainice can identify subtle product variations more accurately and steadily enhance operational reliability.

The nationwide sales and service network also centers on supporting chronic disease monitoring. All staff receive specialized training on blood glucose equipment, capable of offering professional operation guidance and consumable matching advice to address common daily monitoring issues faced by diabetics. Adhering to the development philosophy of "specialization brings excellence", Hainice avoids blind business expansion. Over sixteen years of dedicated efforts in the diabetes monitoring niche, it has built a domestically trusted medical device brand with highly specialized R&D, production and service systems.